Aerosol of hydrogen peroxide
OtherSpray of aerosolized peroxide hydrogen using a specific device when performing terminal cleaning of the ICU bed after the patient's discharge.
Other names: Hydrogen Peroxide
NCT Number: NCT07233837
Healthcare-associated infections (HAIs) remain a major problem in intensive care units (ICUs), driven by environmental contamination with multidrug-resistant organisms that persist despite routine manual cleaning. While hydrogen peroxide aerosolization and ultraviolet-C light devices have shown promise in reducing surface contamination, current evidence is inconsistent, mostly derived from single-center studies, and rarely linked to patient-centered outcomes.
The investigators will conduct this cluster-randomized, crossover trial in 12 Brazilian ICUs. Each ICU will sequentially implement three strategies: (1) usual surface disinfection; (2) usual surface disinfection followed by hydrogen peroxide aerosolization at 7.9% concentration, applied through a dedicated device inside a protective tent during terminal cleaning of patient beds; and (3) usual surface disinfection followed by automated ultraviolet-C irradiation, also applied under the same tent to shield adjacent occupied beds.
The primary outcome will be the antimicrobial utilization, measured as daily defined doses (DDD) of antimicrobials at the ICU level per 100 patient-days, with secondary outcomes including HAI incidence rate, environmental contamination with multidrug-resistant organisms, specific HAIs incidence rate (associated-ventilator pneumonia, central-line associated bloodstream infection, and catheter-associated urinary tract infection), and ICU length of stay costs.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Hospital Maternidade Sao Vicente De Paulo, Barbalha, Ceará, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Spray of aerosolized peroxide hydrogen using a specific device when performing terminal cleaning of the ICU bed after the patient's discharge.
Other names: Hydrogen Peroxide
Irradiation of UV light for the purpose of disinfecting beds and surfaces near beds during terminal cleaning.
Other names: Ultraviolet light
Time frame: 3 months
Antimicrobial utilization, measured as daily defined doses (DDD) of antimicrobials at the ICU level per 100 patient-days
Time frame: 3 months
Incidence rate of device healthcare-associated infections during ICU admission
Time frame: 3 months
We will collect environmental samples from 4 surfaces highly touched by the patient, health team and family (bed rails, monitor and infusion pump buttons, meal table or procedure table, and IV drip stand) before and after the intervention. For analysis of the environmental samples, characterization of the density and microbiological profile of biofilms on the different surfaces of the ICU beds will be performed using large-scale DNA sequencing techniques associated with bioinformatics analysis.
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Contact information is provided by the study sponsor or research team.
Adriano J Pereira, PhD
CONTACT
Antonio P Nassar Jr, PhD
CONTACT
Hospital Israelita Albert Einstein
Other
Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units: A Randomized, Controlled, Cluster, Crossover Clinical Trial
Acronym: Hylight
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05673226
Catheter-Related Infections, Cross Infection
Belém, Brazil
View Trial DetailsNCT05153694
Bacterial Infections, Bacterial Infections and Mycoses
Munich, Outside U.S./Canada, Germany
View Trial DetailsNCT05475574
Cross Infection, Disease Attributes
Metz, France
View Trial DetailsNCT03391960
Cross Infection, Disease Attributes
Maplewood, Minnesota, United States
View Trial Details